| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 16, 2026 | ±1.9% | -0.2% | over-priced |
| October 16, 2025 | ±2.8% | -2.9% | under-priced |
| July 17, 2025 | ±1.6% | +3.8% | under-priced |
| April 16, 2025 | ±3.5% | +1.1% | over-priced |
| October 17, 2024 | ±1.7% | +9.0% | under-priced |
| July 19, 2024 | ±1.8% | -7.8% | under-priced |
| April 17, 2024 | ±1.6% | -7.4% | under-priced |
| October 18, 2023 | ±1.7% | -0.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $7.78 | $11.9B | $1.7B |
| Q4 FY2025 | $10.98 | $12.4B | $2.5B |
| Q3 FY2025 | $8.24 | $12.5B | $1.9B |
| Q2 FY2025 | $6.53 | $12.1B | $1.5B |
The Travelers Companies, Inc. (TRV) reports in 78 days, with the next report estimated for August 30, 2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 4.1% on average — the market has been roughly fair on TRV's earnings risk. Fundamentals into the print: EPS up 357.6% year-over-year, revenue up 1.0%. QuantLogix's live 5-factor engine currently reads TRV as a buy at 60/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →